Thomas K. Baker
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Toxic Organic Pollutants Impact 3
-
- Computational Drug Discovery Methods 5
- Co-authors
- James L. Stevens (4 shared papers)James E. Klaunig (7 shared papers)George H. Searfoss (5 shared papers)Mark A. Carfagna (3 shared papers)Timothy P. Ryan (4 shared papers)Hong Tao Gao (3 shared papers)Ann P. Kwiatkowski (2 shared papers)Ernst R. Dow (1 shared paper)
- Journals
- Toxicological Sciences (4 papers)Toxicology Letters (3 papers)Weed Technology (3 papers)Drug Discovery Today (2 papers)Drug Metabolism and Disposition (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Thomas K. Baker
31 papers receiving 871 citations
Peers
Comparison fields: 5 of 101
- Pharmacology 137
- Hepatology 78
- Health, Toxicology and Mutagenesis 107
- Cancer Research 89
- Computational Theory and Mathematics 111
Countries citing papers authored by Thomas K. Baker
This map shows the geographic impact of Thomas K. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas K. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas K. Baker more than expected).
Fields of papers citing papers by Thomas K. Baker
This network shows the impact of papers produced by Thomas K. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas K. Baker. The network helps show where Thomas K. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas K. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 236 | |
| 2 | 2001 | 124 | |
| 3 | 1995 | 53 | |
| 4 | 2012 | 48 | |
| 5 | 2003 | 46 | |
| 6 | 1995 | 45 | |
| 7 | 2003 | 33 | |
| 8 | 2020 | 33 | |
| 9 | 2007 | 32 | |
| 10 | 2010 | 30 | |
| 11 | 1990 | 27 | |
| 12 | 1994 | 26 | |
| 13 | 2021 | 23 | |
| 14 | 2006 | 20 | |
| 15 | 2021 | 19 | |
| 16 | 2013 | 18 | |
| 17 | 2016 | 18 | |
| 18 | 2024 | 16 | |
| 19 | Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. | 1995 | 15 |
| 20 | 2023 | 14 |
About Thomas K. Baker
Thomas K. Baker is a scholar working on Health, Toxicology and Mutagenesis, Computational Theory and Mathematics, Small Animals, Immunology and Cancer Research, having authored 32 papers that have together received 929 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Connexins and lens biology (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Gene expression and cancer classification (3 papers), Animal testing and alternatives (3 papers), Toxic Organic Pollutants Impact (3 papers) and 3D Printing in Biomedical Research (2 papers). The work is most often cited by research in Pharmacology (137 citations), Hepatology (78 citations), Health, Toxicology and Mutagenesis (107 citations), Cancer Research (89 citations) and Computational Theory and Mathematics (111 citations). Thomas K. Baker has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James L. Stevens, James E. Klaunig, George H. Searfoss, Mark A. Carfagna, Timothy P. Ryan, Hong Tao Gao, Ann P. Kwiatkowski, Ernst R. Dow, Qingqin S. Li and Thomas F. Peeper. Their work appears in journals such as Toxicological Sciences, Toxicology Letters, Weed Technology, Drug Discovery Today and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.